AlphAIAlphAI — Financial news for AI agents
simplywall.stAUG 75 min read$BFLY

Butterfly Network (BFLY) Could Be 18% Overvalued Following Raised Guidance And Earnings Beat

Simply Wall St reports Butterfly Network (BFLY) raised its 2026 revenue outlook to $119 million to $123 million and increased third-quarter guidance after its latest earnings. The article cites a fair value of $7.06 versus a $8.30 close, and a consensus price target of $7.06, with analyst targets ranging from $5.25 to $11.0.

Original reporting
simplywall.st
Published Aug 7, 2026, 3:54 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 7, 2026, 7:17 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$BFLY
Bullish
medium confidence
Mentioned
$BFLY
Relevance
7/10
AlphAI data visualization · based on simplywall.st
Decision brief

The 30-second read

$BFLYBullishMed
01

Why it matters

Traders can reassess near-term expectations based on the updated 2026 revenue range and higher Q3 guidance, but should weigh the stated overvaluation and ongoing loss/profitability risks.

02

Market read

Guidance-up and earnings-beat details are the core catalyst, while the valuation narrative (fair value vs last close) highlights potential downside if expectations slip.

03

What to watch

Losses persist and the piece cites high R&D spending and leadership-change risk, which could undermine the profitability step-change the valuation narrative assumes.

Relevance 7/10Novelty 6/10Timing: post-earnings, guidance update driving renewed attention

Background

The article frames Butterfly Network as returning to investor focus after a guidance raise and an earnings beat, alongside strong recent share performance.

Company-level read

Ticker impact

$BFLYBullishMedium confidence
Context

Butterfly Network raised 2026 revenue guidance to $119M-$123M and issued higher Q3 guidance after its latest earnings report.

Expected impact

Near-term upside bias from guidance momentum, tempered by overvaluation narrative and profitability risk.

Evidence & confidence

The text provides specific guidance ranges and a valuation comparison (fair value vs last close), plus stated risks (high R&D, leadership changes).

Market effects

Sector

Supports the broader healthcare AI narrative that investors may re-rate companies showing guidance acceleration and profitability inflection.

Regional

No specific regional market linkage provided in the article.

Global

No explicit global catalyst beyond the company’s guidance and valuation discussion.

Counterpoint

What could challenge this read

The article’s own valuation framing suggests the stock may already price in a large portion of the improvement, limiting upside even if guidance is raised.

Key entities

  • company
    Butterfly Network

    Raised 2026 revenue outlook to $119M-$123M and issued higher Q3 guidance after its latest earnings report.

Read at source← All news

Related articles

OCT 12
$QSIMed

2 Brain-Computer Interface Stocks to Watch While Neuralink Stays Private

Neuralink, a private brain-computer interface (BCI) company, successfully helped a patient with ALS communicate. Investors cannot buy Neuralink, but two public companies, Quantum-Si (QSI) and Butterfly Network (BFLY), are connected to the BCI field. QSI makes research tools and saw a 7x volume spike, while BFLY supplies ultrasound chips to BCI developers like Merge Labs and Bridge Neurotech.

investorplace.com3 min
OCT 12
$BFLYHigh

Why is Butterfly Network stock climbing today?

Butterfly Network (BFLY) stock rose 1.6% pre-market after Canaccord Genuity initiated coverage with a Buy rating and $10 target, citing its ultrasound tech and AI capabilities. Analysts highlight new products and partnerships. The stock has seen positive analyst activity, with a consensus target of $11.40. Q3 earnings are due October 29.

investing.com2 min
SEP 29
$BFLYHigh

Evercore ISI initiates Butterfly Network stock with outperform rating

Evercore ISI initiated coverage on Butterfly Network (NYSE: BFLY) with an outperform rating and $15.00 price target, citing its ultrasound-on-chip technology and growth potential. The firm projects $550M+ revenue by 2030 and positive EBITDA by 2028. BFLY stock has risen 367% over the past year, trading at $9.15 with a $2.44B market cap. Q2 2026 results showed a smaller loss than expected but lower revenue. Needham also initiated coverage with a buy rating and $10.00 target.

investing.com2 min
SEP 22
$BFLYHighAI 8/10

Why is Butterfly Network stock surging today?

Butterfly Network (BFLY) stock rose 11.5% after Needham initiated coverage with a Buy rating and $10 target, citing its ultrasound tech and Embedded business model. TD Cowen also has a Buy rating and $10 target. BFLY's Q3 revenue grew 39% YoY, with Embedded segment growth and expanding margins. The broader market had minimal impact on BFLY's surge.

investing.com2 min
SEP 15
$BFLYMed

Butterfly Network at Morgan Stanley conference: platform push widens reach

Butterfly Network (BFLY) presented its strategy at Morgan Stanley's conference, shifting from handheld ultrasound to a semiconductor imaging platform. The company reported 20% revenue growth, with $112M in last 12-month revenue, and highlighted partnerships like Midjourney. It aims to expand its addressable market to $250B through its Butterfly Embedded model. The company expects a fourth-generation chip in 2027 to improve image quality and challenge competitors. Management emphasized its strong

investing.com2 min
AUG 8
$BFLYMed

Butterfly Network (BFLY) Is Up 24.2% After Raising 2026 Guidance And Narrowing Losses - Has The Bull Case Changed?

Butterfly Network (BFLY) shares rose 24.2% after the company reported Q2 2026 revenue of $32.61M and a reduced net loss of $12.91M, and raised 2026 revenue guidance to $119M to $123M. The article cites improving losses and momentum in Embedded partnerships and enterprise point-of-care ultrasound, while noting ongoing cash burn and potential dilution risks.

simplywall.st4 min